News | March 09, 2022
Indian Pharma Market growth flat in Feb 2022
Price was the key driver for the period
Price was the key driver for the period
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
Dr Ratna Puri from Sir Ganga Ram Hospital, Delhi is the Chairperson of the expert committee.
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
Women's health is in fact a direct reflection of the nation's overall health
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Subscribe To Our Newsletter & Stay Updated
